Sean Bohen

NetSuite Mimecast Outlook Microsoft Office 365 Greenhouse.io Google Cloud Hosting WP Engine Adobe Marketing Cloud WordPress.org Google Tag Manager Nginx Vimeo Mobile Friendly Typekit Simpli.fi YouTube Remote

pharmaceuticals biotechnology drug development oncology breast cancer nuclear receptors small molecules drug discovery life sciences biotechnology: pharmaceutical preparations health care biotechnology research targeted therapies kat6 inhibitor er+ breast cancer metastatic disease palazestrant hormone receptor positive complete estrogen receptor antagonist selective estrogen receptor degrader endocrine therapy clinical trials anti-tumor activity biopharmaceutical patient care personalized medicine cancer treatments combination therapy clinical-stage fda approval safety & efficacy pharmacodynamics pharmacokinetics novel therapies malignant tumor suppression her2-negative mutation inhibition tumor growth reduction therapeutic efficacy oncology expertise investor relations market research new drug application patient experience team collaboration scientific approach convenient treatments favorable pharmacokinetic attributes therapy resistance clinical data preclinical models advancing patient care oncology clinical studies patient survival financial results biopharmaceuticals innovative treatments precision medicine estrogen receptor antagonist op-1250 op-3136 hormone-dependent cancers unmet medical needs personalized treatment cancer research healthcare partnerships patient support advanced therapies molecular characteristics cancer progression therapeutic innovation women's health er+/her2- breast cancer drug pipeline biotechnology sector cancer treatment development medical hospital & health care health wellness & fitness